Dr. Lin is one of the two recipients of the 2022 Early Career Development Pilot Grant, awarded by the Herbert Irving Comprehensive Cancer Center (HICCC).
A new study, lead by Dr. Kevin Gardner, highlights a prognostic biomarker called Kaiso that may provide some insight into the biological reasons for racial disparities in breast cancer.
Expanded genomic panel testing was clinically impactful in most patients with high-risk cancer, yet payers reimbursed only 10.75% of the charge on average, if reimbursed at all, new study found.
Findings provide new insight into the link between seizures and tumor progression; can help develop improved diagnostics and treatments for deadly form of brain cancer
In this study, the authors reported on a single-institution experience on 3-year prospective PSCPC regarding risk of malignancy (ROM) and the overall risk of malignancy (OROM).
Piero Dalerba, MD is one of the six inaugural Velocity fellows, whose innovative research projects to solve cancer are being funded by the money raised from the Velocity ride.
On January 18, 2018, the Department held the 29th Kenneth Naidorf Memorial Lecture.The invited lecturer, Dr. Elaine Fuchs, is the Rebecca C. Lancefield Professor at Rockefeller University.
Pathology and Cell Biology faculty Antonio Iavarone and Anna Lasorella co-authored study about gene fusion effect on cellular activity and its relation to some cancer featured in Nature.